Industry: Pharmaceuticals, Biotechnology
Novocell, Inc. is a stem cell engineering company with research operations in Irvine and San Diego, CA, and Athens, GA, dedicated to creating, delivering and commercializing cell and drug therapies for diabetes and other chronic diseases. Novocell is the first company to efficiently engineer human embryonic stem cells into definitive endoderm, the gatekeeper cells that differentiate into many other cells, tissues and organs. Novocell has three primary technologies: stem cell-directed lineage, encapsulation and drug discovery. The company was founded in 1999 and merged with CyThera and BresaGen in 2004. Novocell’s goal is to develop a renewable source of specialized cells that can be used to treat chronic ( www.novocell.com )
Novocell , Inc.
3550 General Atomics Court Building 2-503
San Diego, California 92121
USA
Tel: (858) 455-3708
Fax: (858) 455-3962